Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Breast-cancer"

216 News Found

HCG launches breast Cancer Care Clinic in Bengaluru
Healthcare | June 23, 2026

HCG launches breast Cancer Care Clinic in Bengaluru

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted


Indian scientists develop precision nanomedicine for breast cancer
R&D | June 04, 2026

Indian scientists develop precision nanomedicine for breast cancer

DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity


Abbott highlights prognostic value of MRD testing for breast cancer recurrence
Clinical Trials | June 03, 2026

Abbott highlights prognostic value of MRD testing for breast cancer recurrence

New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients


FDA fast-tracks Roche’s giredestrant review as data signal potential shift in early breast cancer care
Drug Approval | June 03, 2026

FDA fast-tracks Roche’s giredestrant review as data signal potential shift in early breast cancer care

The filing is backed by Phase III data from the lidERA Breast Cancer study


Datroway wins US nod in aggressive breast cancer subtype
Drug Approval | May 25, 2026

Datroway wins US nod in aggressive breast cancer subtype

Clearance marks major shift beyond chemotherapy


AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
Clinical Trials | May 25, 2026

AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%

The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial


FDA expands Enhertu use in early HER2-positive breast cancer
Drug Approval | May 19, 2026

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease


FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer
News | May 04, 2026

FDA advisory panel narrowly withholds support for AstraZeneca’s combo in breast cancer

The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor


GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


ENHERTU approved in China as first HER2-targeted ADC for early breast cancer
Drug Approval | March 31, 2026

ENHERTU approved in China as first HER2-targeted ADC for early breast cancer

The decision is based on the phase 3 DESTINY-Breast11 trial